News | January 06, 2024
Supriya Lifesciences received GMP certification from ANVISA Brazil
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Receives registration of Valganciclovir powder for oral solution in Germany
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Both the India and GCC entities will be operated by separate dedicated management teams
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Phase 3 data expected in the second half of 2024
The company reported net profit after share of profit/loss of JV and minority interest at Rs. 752 crore vs. Rs. 409 crore in Q2FY23
Subscribe To Our Newsletter & Stay Updated
